Concepedia

Author

Charles Link

NewLink Genetics (United States)

Also Known As

C Link, C. Link, Charles E. Link, Charles Link, Minton, Susan

48

Publications

1.3K

Citations

20

H-Index

56

Concepts

All Affiliations

NewLink Genetics (United States)Northwestern UniversityNational Cancer InstituteMoffitt Cancer CenterIowa State University
CL

About

Charles Link is an author at NewLink Genetics (United States) specializing in medicine, cancer therapeutics, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

11

11

468

2

Cell Biology

4

4

190

3

Health Sciences

3

3

164

4

Cellular Therapies

2

2

154

5

Biochemistry

1

1

33

Charles Link

×

22

Publications

1.2K

Citations

18

H-Index

YearCitations

Dose-Intense Taxol: High Response Rate in Patients With Platinum-Resistant Recurrent Ovarian Cancer

Elise C. Kohn, Gisele Sarosy, Annette Bicher,

JNCI Journal of the National Cancer Institute

1994

193

A first in man phase I trial of the oral immunomodulator, indoximod, combined with docetaxel in patients with metastatic solid tumors

Hatem Soliman, Erica L. Jackson, Tony Neuger,

Oncotarget

2014

170

A phase I study of indoximod in patients with advanced malignancies

Hatem Soliman, Susan Minton, Hyo S. Han,

Oncotarget

2016

141

Safety and immunogenicity of the rVSV∆G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study

D. Gray Heppner, Tracy Kemp, Brian K. Martin,

The Lancet Infectious Diseases

2017

118

Embryonic Stem Cells As an Alternate Marrow Donor Source

Richard K. Burt, Larissa Verda, Duck-An Kim,

The Journal of Experimental Medicine

2004

111

Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer

Veronica Mariotti, Hyo S. Han, Roohi Ismail‐Khan,

JAMA Oncology

2020

45

Hematopoietic Mixed Chimerism Derived from Allogeneic Embryonic Stem Cells Prevents Autoimmune Diabetes Mellitus in NOD Mice

Larissa Verda, Duck-An Kim, Susumu Ikehara,

Stem Cells

2007

43

Herpes simplex thymidine kinase gene–transduced donor lymphocyte infusions

Richard K. Burt, William R. Drobyski, Tatiana Seregina,

Experimental Hematology

2003

43

Discovery of indoximod prodrugs and characterization of clinical candidate NLG802

Sanjeev Kumar, Firoz A. Jaipuri, Jesse P. Waldo,

European Journal of Medicinal Chemistry

2020

38

Abstract CT117: Interim analysis of the Phase 2 clinical trial of the IDO pathway inhibitor indoximod in combination with pembrolizumab for patients with advanced melanoma

Yousef Zakharia, Robert R. McWilliams, M. Shaheen,

Cancer Research

2017

37

Page 1